Interaction of RU 486, A Glucocorticoid and Progestin Antagonist with Human Circulating Mononuclear Leukocytes
- 1 September 1989
- journal article
- research article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 298 (3) , 167-171
- https://doi.org/10.1097/00000441-198909000-00004
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Stimulation of Prostaglandin Production by Two Antiprogesterone Steroids in Human Endometrial CellsJournal of Clinical Endocrinology & Metabolism, 1986
- Binding of glucocorticoid antagonists to androgen and glucocorticoid hormone receptors in rat skeletal muscleJournal of Steroid Biochemistry, 1986
- Successful Treatment of Cushing’s Syndrome with the Glucocorticoid Antagonist RU 486*Journal of Clinical Endocrinology & Metabolism, 1985
- Effects of the Antiprogesterone Steroid RU 486 during Midluteal Phase in Normal WomenJournal of Clinical Endocrinology & Metabolism, 1985
- RU 38486: A potent antiglucocorticoid in vitro and in vivoThe Journal of Steroid Biochemistry and Molecular Biology, 1985
- Increased Adrenocorticotropin, Cortisol, and Arginine Vasopressin Secretion in Primates after the Antiglucocorticoid Steroid RU 486:Dose Response Relationships*Journal of Clinical Endocrinology & Metabolism, 1985
- The New Steroid Analog RU 486 Inhibits Glucocorticoid Action in ManJournal of Clinical Endocrinology & Metabolism, 1984
- RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day.Proceedings of the National Academy of Sciences, 1984
- Termination of very early pregnancy by RU 486 — An antiprogestational compoundContraception, 1984
- Binding of the anti-progestin ru-486 to rat ovary steroid receptorsContraception, 1983